CLNN

Clene Inc. Common Stock
Data: 2026-02-02
$4.01
Price
0.00%
Change
$13.5
52W High
$2.2801
52W Low

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Quick Stats
Feb 02, 2026

39.4

AI Score

SELL

0.53

Volume Ratio

Mar 23, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

CLNN Stock Summary

Last updated Feb 02, 2026

CLNN is currently trading at $4.01, positioned below its 200-day moving average of $5.59, suggesting bearish momentum. The stock has a 52-week range of $2.2801 to $13.5.

Technical Analysis: The 50-day moving average stands at $6.47, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 31.192, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.207, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CLNN at 39.4/100 with a SELL recommendation.

CLNN (Clene Inc. Common Stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 31.192
CMF (20) -0.207
ROC (10) -19.01
ADX (14) 29.924
Indicator Value
MACD (12,26,9) -0.591
AROONOSC (14) -100.0
WILLAMS %R (14) -93.719
MFI (14) 38.005
CLNN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CLNN Price vs Max Options Open Interest
CLNN Max Change In Options Open Interest

CLNN Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CLNN Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CLNN Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CLNN Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Clene Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CLNN Moving Averages Analysis

CLNN (Clene Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 4.82
20 5.21
30 5.52
50 6.47
100 7.36
200 5.59

CLNN Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 48.2 million
Earnings/Share ($) -3.36
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.1733
EPS Estimate Next Year ($) -2.0633
WallStreet Target Price ($) 31.8571
Most Recent Quarter